Skip to main content
Top
Published in: Journal of General Internal Medicine 4/2007

01-04-2007 | Original Article

Long-Term Opioid Contract Use for Chronic Pain Management in Primary Care Practice. A Five Year Experience

Authors: Jaishree Hariharan, MD, Geoffrey C. Lamb, MD, Joan M. Neuner, MD, MPH

Published in: Journal of General Internal Medicine | Issue 4/2007

Login to get access

Background

The use of opioid medications to manage chronic pain is complex and challenging, especially in primary care settings. Medication contracts are increasingly being used to monitor patient adherence, but little is known about the long-term outcomes of such contracts.

Objective

To describe the long-term outcomes of a medication contract agreement for patients receiving opioid medications in a primary care setting.

Design

Retrospective cohort study.

Subjects

All patients placed on a contract for opioid medication between 1998 and 2003 in an academic General Internal Medicine teaching clinic.

Measurements

Demographics, diagnoses, opiates prescribed, urine drug screens, and reasons for contract cancellation were recorded. The association of physician contract cancellation with patient factors and medication types were examined using the Chi-square test and multivariate logistic regression.

Results

A total of 330 patients constituting 4% of the clinic population were placed on contracts during the study period. Seventy percent were on indigent care programs. The majority had low back pain (38%) or fibromyalgia (23%). Contracts were discontinued in 37%. Only 17% were cancelled for substance abuse and noncompliance. Twenty percent discontinued contract voluntarily. Urine toxicology screens were obtained in 42% of patients of whom 38% were positive for illicit substances.

Conclusions

Over 60% of patients adhered to the contract agreement for opioids with a median follow-up of 22.5 months. Our experience provides insight into establishing a systematic approach to opioid administration and monitoring in primary care practices. A more structured drug testing strategy is needed to identify nonadherent patients.
Literature
1.
go back to reference Adams NJ, Plane MB, Fleming MF, Mundt MP, Saunders LA, Stauffacher EA. Opioids and the treatment of chronic pain in a primary care sample. J Pain Symptom Manage. 2001;22:791–6.PubMedCrossRef Adams NJ, Plane MB, Fleming MF, Mundt MP, Saunders LA, Stauffacher EA. Opioids and the treatment of chronic pain in a primary care sample. J Pain Symptom Manage. 2001;22:791–6.PubMedCrossRef
2.
go back to reference Guerje O, Von Korff M, Simon GE, Gater R. Persistent pain and well being. A World Health Organization study in primary care. JAMA. 1998;280:147–51.CrossRef Guerje O, Von Korff M, Simon GE, Gater R. Persistent pain and well being. A World Health Organization study in primary care. JAMA. 1998;280:147–51.CrossRef
3.
go back to reference Reid MC, Engles-Horton LL, Weber MB, Kerns RD, Rogers EL, O’Connor PG. Use of opioid medications for chronic noncancer pain syndromes in primary care. J Gen Intern Med. 2002;17:173–9.PubMedCrossRef Reid MC, Engles-Horton LL, Weber MB, Kerns RD, Rogers EL, O’Connor PG. Use of opioid medications for chronic noncancer pain syndromes in primary care. J Gen Intern Med. 2002;17:173–9.PubMedCrossRef
4.
go back to reference Chelminski PR, Ives TJ, Felix KM. A primary care, multi-disciplinary pain management program for opioid-treated patients with chronic non-cancer pain and a high burden of psychiatric co-morbidity. BMC Health Serv Res. 2005;5(1):3.PubMedCrossRef Chelminski PR, Ives TJ, Felix KM. A primary care, multi-disciplinary pain management program for opioid-treated patients with chronic non-cancer pain and a high burden of psychiatric co-morbidity. BMC Health Serv Res. 2005;5(1):3.PubMedCrossRef
5.
go back to reference Portenoy RK, Foley KM. Chronic use of opioid analgesics in nonmalignant pain: report of 38 cases. Pain. 1986;25:171–86.PubMedCrossRef Portenoy RK, Foley KM. Chronic use of opioid analgesics in nonmalignant pain: report of 38 cases. Pain. 1986;25:171–86.PubMedCrossRef
6.
go back to reference Turk DC. Clinical effectiveness and cost-effectiveness of treatments. Clin J Pain. 2002;18:355–65.PubMedCrossRef Turk DC. Clinical effectiveness and cost-effectiveness of treatments. Clin J Pain. 2002;18:355–65.PubMedCrossRef
7.
go back to reference Portenoy RK. Opioid therapy for chronic nonmalignant pain: a review of the critical issues. J Pain Symptom Manage. 1996;11:203–17.PubMedCrossRef Portenoy RK. Opioid therapy for chronic nonmalignant pain: a review of the critical issues. J Pain Symptom Manage. 1996;11:203–17.PubMedCrossRef
8.
go back to reference Bendson P, Hensing G, Ebeling C, Schedin A. What are the qualities of dilemmas experienced when prescribing opioids in general practice? Pain. 1999;82:89–96.CrossRef Bendson P, Hensing G, Ebeling C, Schedin A. What are the qualities of dilemmas experienced when prescribing opioids in general practice? Pain. 1999;82:89–96.CrossRef
9.
go back to reference Fishman SM, Wilsey B, Yang J, Reisfield GM, Bandman TB, Borsook DB. Adherence monitoring and drug surveillance in chronic opioid therapy. J Pain Symptom Manage. 2000;20(4):293–307.PubMedCrossRef Fishman SM, Wilsey B, Yang J, Reisfield GM, Bandman TB, Borsook DB. Adherence monitoring and drug surveillance in chronic opioid therapy. J Pain Symptom Manage. 2000;20(4):293–307.PubMedCrossRef
10.
11.
go back to reference Sanders SH, Harden RN, Benson SE, Vicente PJ. Clinical practice guidelines for chronic non-malignant pain syndrome patients II: an evidence-based approach. J Back Musculoskelet Rehabil. 1999;13:47–58. Sanders SH, Harden RN, Benson SE, Vicente PJ. Clinical practice guidelines for chronic non-malignant pain syndrome patients II: an evidence-based approach. J Back Musculoskelet Rehabil. 1999;13:47–58.
12.
go back to reference Practice guidelines for chronic pain management. A report by the American Society of Anesthesiologists Task Force on Pain Management. Chronic Pain Section. Anesthesiology. 1997;86:995–04. Practice guidelines for chronic pain management. A report by the American Society of Anesthesiologists Task Force on Pain Management. Chronic Pain Section. Anesthesiology. 1997;86:995–04.
13.
go back to reference American Academy of Pain Medicine and American Pain Society. The use of opioids for the treatment of chronic pain. A consensus statement. Clin J Pain. 1997;13:6–8.CrossRef American Academy of Pain Medicine and American Pain Society. The use of opioids for the treatment of chronic pain. A consensus statement. Clin J Pain. 1997;13:6–8.CrossRef
14.
go back to reference Guidelines for the assessment and management of chronic pain. Wisconsin Medical Society Taskforce on Pain Management. WMJ. 2004;103(3):15–42. Guidelines for the assessment and management of chronic pain. Wisconsin Medical Society Taskforce on Pain Management. WMJ. 2004;103(3):15–42.
15.
go back to reference Donovan MI, Evers K, Jacobs P, Mandleblatt S. When there is no benchmark: designing a primary care-based chronic pain management program from the scientific basis up. J Pain Symptom Manage. 1999;18:38–48.PubMedCrossRef Donovan MI, Evers K, Jacobs P, Mandleblatt S. When there is no benchmark: designing a primary care-based chronic pain management program from the scientific basis up. J Pain Symptom Manage. 1999;18:38–48.PubMedCrossRef
16.
go back to reference Quill TE. Partnerships in patient care: a contractual approach. Ann Intern Med. 1983;98:228–34.PubMed Quill TE. Partnerships in patient care: a contractual approach. Ann Intern Med. 1983;98:228–34.PubMed
17.
go back to reference Miller LJ. The formal treatment contract in the inpatient management of borderline personality disorder. Hospital and Community Psychiatry. 1990;41:985–7.PubMed Miller LJ. The formal treatment contract in the inpatient management of borderline personality disorder. Hospital and Community Psychiatry. 1990;41:985–7.PubMed
18.
go back to reference Hariharan J, Denson KM. A challenging patient, an innovative solution. WMJ. 2005;104(8):72–5.PubMed Hariharan J, Denson KM. A challenging patient, an innovative solution. WMJ. 2005;104(8):72–5.PubMed
19.
go back to reference Fishman SM, Bandman TB, Edwards A, Borsook D. The opioid contract in the management of chronic pain. J Pain Symptom Manage. 1999;18(1):27–37.PubMedCrossRef Fishman SM, Bandman TB, Edwards A, Borsook D. The opioid contract in the management of chronic pain. J Pain Symptom Manage. 1999;18(1):27–37.PubMedCrossRef
20.
go back to reference Fishman SM, Kreis PG. The opioid contract. Clin J Pain. 2003;18(4)(Supp):S70–S75. Fishman SM, Kreis PG. The opioid contract. Clin J Pain. 2003;18(4)(Supp):S70–S75.
21.
go back to reference Arnold RM, Han PKJ, Seltzer D. Opioid contracts in chronic nonmalignant pain management: objectives and uncertainties. Am J Med. 2006;119(4):292–6.PubMedCrossRef Arnold RM, Han PKJ, Seltzer D. Opioid contracts in chronic nonmalignant pain management: objectives and uncertainties. Am J Med. 2006;119(4):292–6.PubMedCrossRef
22.
go back to reference Robinson RC, et al. Screening for problematic prescription opioid use. Clin J Pain. 2001;17(3):220–5.PubMedCrossRef Robinson RC, et al. Screening for problematic prescription opioid use. Clin J Pain. 2001;17(3):220–5.PubMedCrossRef
23.
go back to reference Chabel C, Erjavec MK, Jacobson L, et al. Prescription opiate abuse in chronic pain patients: clinical criteria, incidence, and predictors (see comments). Clin J Pain. 1997;12:150–5.CrossRef Chabel C, Erjavec MK, Jacobson L, et al. Prescription opiate abuse in chronic pain patients: clinical criteria, incidence, and predictors (see comments). Clin J Pain. 1997;12:150–5.CrossRef
25.
go back to reference Katz N, Fanciullo GJ. Role of urine toxicology testing in the management of chronic opioid therapy. Clin J Pain. 2002;18(4)(suppl):S76–S82. Katz N, Fanciullo GJ. Role of urine toxicology testing in the management of chronic opioid therapy. Clin J Pain. 2002;18(4)(suppl):S76–S82.
26.
go back to reference Heit HA, Gourlay DL. Urine drug testing in pain medicine. J Pain Symptom Manage. 2004;27(3):260–7.PubMedCrossRef Heit HA, Gourlay DL. Urine drug testing in pain medicine. J Pain Symptom Manage. 2004;27(3):260–7.PubMedCrossRef
27.
go back to reference Katz NP, et al. Behavioral monitoring and urine toxicology testing in patients receiving long-term opioid therapy. Anesth Analg. 2003;97:1097–102.PubMedCrossRef Katz NP, et al. Behavioral monitoring and urine toxicology testing in patients receiving long-term opioid therapy. Anesth Analg. 2003;97:1097–102.PubMedCrossRef
Metadata
Title
Long-Term Opioid Contract Use for Chronic Pain Management in Primary Care Practice. A Five Year Experience
Authors
Jaishree Hariharan, MD
Geoffrey C. Lamb, MD
Joan M. Neuner, MD, MPH
Publication date
01-04-2007
Publisher
Springer-Verlag
Published in
Journal of General Internal Medicine / Issue 4/2007
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-006-0084-1

Other articles of this Issue 4/2007

Journal of General Internal Medicine 4/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.